866-407-4380

Drug Rehab Connecticut is here to help people with drug and/or alcohol abuse problems in Connecticut. find treatment options. Due to our diverse networking system we can find a treatment option tailored to each individuals specific situation and needs. We are able to provide all phases of recovery included but not limited to, alcohol and/or drug intervention, drug and/or alcohol detox, in-patient treatment, out-patient treatment, short term treatment (30 days or less), long term treatment (90 days or longer).

We design personalized treatment programs to provide each abuser with the greatest chance of a successful recovery outcome. Our comprehensive networking system works hand in hand with all of the drug treatment centers in Connecticut. At Drug Rehab Connecticut we know that each individual is unique and are treated as such. Deciding upon a treatment option in Connecticut, or anywhere can be a daunting task for any individual or family, we will guide you through each step of a comprehensive treatment plan for you or your loved one. We are determined in our mission, that every drug and/or alcohol abuser in Connecticut. that has a desire to change their life will be given a chance to recover from their addiction and we are dedicated to ensuring that they are given the opportunity to do so. We realize that each individual in Connecticut. is in a different financial situation and we will find treatment options for each individual regardless of their financial situation. No matter what your financial situation everyone will receive the treatment help they are looking for.          866-407-4380

Hydrocodone Info

Hydrocodone is an orally active analgesic and antitussive Schedule II narcotic that is marketed in multi-ingredient Schedule III products. Hydrocodone has an analgesic potency similar to or greater than that of oral morphine. Sales and production of this drug have increased significantly in recent years (a four-fold increase between 1990 and 2000), as have diversion and illicit use. Trade names include Anexsia®, Hycodan®, Hycomine®, Lorcet®, Lortab®, Tussionex®, Tylox®, Vicodin®, and Vicoprofen®. These are available as tablets, capsules, and/or syrups. Generally; this drug is abused by oral rather than intravenous administration. Currently, about 20 tons of hydrocodone products are used annually in the United States.

Hydrocodone abuse has been escalating over the last decade. There has been large scale diversion of hydrocodone. For example, an estimated 7 million dosage units were diverted in 1994 and over 11 million in 1997. In 1998 there were over 56 million new prescriptions written for hydrocodone products and by 2000 there were over 89 million. From 1990 the average consumption nationwide has increased by 300%. In the same period there has been a 500% increase in the number of Emergency Department visits attributed to hydrocodone abuse with 19,221 visits estimated in 2000. In 1997, there were over 1.3 million hydrocodone tablets seized and analyzed by the DEA laboratory system. A recent petition submitted to the DEA has requested a review of the control status of all hydrocodone-containing products.

There are over 200 products containing hydrocodone in the U.S. In its most usual product forms hydrocodone is combined with acetaminophen (Vicodin, Lortab), but it is also combined with aspirin (Lortab ASA), ibuprofen (Vicoprofen), and antihistamines (Hycomine). Both tablet and liquid forms of hydrocodone are available (e.g., Tussionex)

Hydrocodone is abused for its opiate-like effects. It is similar to morphine in relieving abstinence symptoms from chronic morphine administration. The Schedule III status of hydrocodone-containing products has made them available to widespread diversion by "bogus call-in prescriptions" and thefts. Three dosage forms are typically found (5, 7.5, and 10 mg) and their behavioral effects can last up to 5 hours. The drug is most often administered orally. The growing awareness and concern about AIDS and blood-borne pathogens easily transmitted by syringe needle use, has made the oral bioavailability of hydrocodone attractive to the typical opiate abuser.

As with most opiates, the adverse effects of hydrocodone abuse are dependence and tolerance development. Its co-formulation with acetaminophen has also increased the likelihood of acetaminophen-induced hepatic necrosis with high dose acute dosing, but slow escalation of dose over time seems to protect the liver during high dose chronic exposures seen with this drug.

Drug Rehab Connecticut Treatment Centers Referral Request First Name Phone (Home) Last Name Phone (Work) Email Address Phone (Cell) Seeking Help For choose Self Son Daughter Spouse Friend Family Other Age Group choose 12 to 17 18 to 25 26+ Main Drug Abused Choose Alcohol Cocaine Marijuana Meth Methadone Ecstasy PCP Speed Heroin LSD XTC Other Contact me by : Phone Home E-Mail Phone Work Phone Cell Any additional questions or comments To submit this form you must type the following number in the box below

Google Bookmarks   —  Share with a friend

Questions and Answers
Submit your Question :
	First Name : City : Security Code: